Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Australian Government IP Australia
Additional fields:

Trade mark 2710842

Words BAMPOVIOS
Image
Image description
Status published: Awaiting indexing
Priority date 15 Oct 2026 (Convention)
Class 5
Kind Word
Dates
Filing 30 Oct 2026

Owner Address for service
Vertex Pharmaceuticals Incorporated
PHILLIPS ORMONDE FITZPATRICK

Goods & Services
Class 5: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders

Convention details
Date 15 Oct 2026
Number 50/163,241
Country UNITED STATES OF AMERICA
Goods & Services
Class 5:
Pharmaceutical preparations for the treatment of immune system related diseases and disorders;pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia;pharmaceutical preparations for the treatment of kidney diseases and disorders;pharmaceutical preparations for the treatment of blood diseases and disorders;pharmaceutical preparations for the treatment of inflammation related diseases and disorders.;pharmaceutical preparations for the treatment of autoimmune diseases and disorders;pharmaceutical preparations for the treatment of immunoglobulin A nephropathy;pharmaceutical preparations for the treatment of primary membranous nephropathy;pharmaceutical preparations for the treatment of lupus nephritis;pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis;pharmaceutical preparations for the treatment of immune thrombocytopenia;pharmaceutical preparations for the treatment of immune thrombocytopenia purpura;pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia

Indexing constituents
Word Image